Quality assurance/ quality control (QA/QC)
Ended Awarded Last action
- Contract number
- HHSN27200001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,220,376
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 26% obligated
-
- $1,220,375.95 Current, with exercised options
- $4,669,061.95 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $20,044 | |
| Funding Only Action | -$289,995 | |
| Funding Only Action | -$317,537 | |
| Funding Only Action | -$484,550 | |
| Exercise an Option | $790,559 | |
| Exercise an Option | $763,839 | |
| Original award | $738,015 |
About this award
The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. The contract is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021 Indefinite Delivery Vehicle (IDV) and has a cost-plus-fixed-fee pricing structure. The contract does not have a set-aside designation. ABL has been awarded several other IDVs with NIAID, NINDS, and NCI, demonstrating its broad capabilities in supporting the development of vaccines, therapeutics, and diagnostics across multiple disease areas for federal health agencies.
Quick answers
Who was awarded contract HHSN27200001?
HHSN27200001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2016.
How much is contract HHSN27200001 worth?
The government has obligated $1,220,376 on HHSN27200001. Its potential value, with all options, is $4,669,062.
Is contract HHSN27200001 an order under another contract?
Yes. HHSN27200001 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract HHSN27200001 competed?
The extent of competition for HHSN27200001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award